Oak Street Health Past Earnings Performance
Past criteria checks 0/6
Oak Street Health's earnings have been declining at an average annual rate of -42.7%, while the Healthcare industry saw earnings growing at 11.6% annually. Revenues have been growing at an average rate of 39.1% per year.
Key information
-42.7%
Earnings growth rate
71.3%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 39.1% |
| Return on equity | n/a |
| Net Margin | -23.6% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Oak Street Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 2,161 | -509 | 507 | 0 |
| 30 Sep 22 | 1,977 | -515 | 501 | 0 |
| 30 Jun 22 | 1,820 | -494 | 483 | 0 |
| 31 Mar 22 | 1,650 | -442 | 446 | 0 |
| 31 Dec 21 | 1,430 | -409 | 420 | 0 |
| 30 Sep 21 | 1,285 | -358 | 404 | 0 |
| 30 Jun 21 | 1,114 | -282 | 369 | 0 |
| 31 Mar 21 | 976 | -159 | 310 | 0 |
| 31 Dec 20 | 883 | -120 | 249 | 0 |
| 30 Sep 20 | 808 | -85 | 190 | 0 |
| 30 Jun 20 | 729 | -93 | 151 | 0 |
| 31 Mar 20 | 641 | -145 | 138 | 0 |
| 31 Dec 19 | 557 | -137 | 122 | 0 |
| 30 Sep 19 | 470 | -119 | 123 | 0 |
| 31 Dec 18 | 318 | -119 | 76 | 0 |
| 31 Dec 17 | 185 | -55 | 33 | 0 |
Quality Earnings: OSH * is currently unprofitable.
Growing Profit Margin: OSH * is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OSH * is unprofitable, and losses have increased over the past 5 years at a rate of 42.7% per year.
Accelerating Growth: Unable to compare OSH *'s earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OSH * is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2.2%).
Return on Equity
High ROE: OSH *'s liabilities exceed its assets, so it is difficult to calculate its Return on Equity.